MicroRNA‑199a‑3p inhibits ovarian cancer cell viability by targeting the oncogene YAP1

Area of Science:

• Oncology
• Molecular Biology
• Biochemistry

Background:

• MicroRNA-199a-3p (miR-199a-3p) shows tumor-suppressive roles in various cancers.
• The specific function of miR-199a-3p in ovarian cancer (OC) is not well-defined.

Purpose of the Study:

• To investigate the role of miR-199a-3p as a tumor suppressor in OC.
• To elucidate the underlying molecular mechanisms of miR-199a-3p in OC.

Main Methods:

• Quantitative real-time PCR to assess miR-199a-3p expression in OC tissues and cell lines.
• Cell viability assays (e.g., MTT) and apoptosis assays (e.g., flow cytometry) in OC cells with miR-199a-3p overexpression.
• Western blotting and luciferase reporter assays to confirm YAP1 as a direct target of miR-199a-3p.
• Rescue experiments involving YAP1 overexpression to validate its role in miR-199a-3p's tumor-suppressive effects.

Main Results:

• miR-199a-3p expression was significantly downregulated in OC tumor tissues, blood samples, and cell lines.
• Low miR-199a-3p expression correlated with advanced International Federation of Gynecology and Obstetrics stage, higher histological grade, and lymph node metastasis.
• Overexpression of miR-199a-3p inhibited OC cell viability and induced apoptosis.
• Yes-associated protein 1 (YAP1) was identified as a direct target of miR-199a-3p, and its expression was inversely correlated with miR-199a-3p in OC tissues.
• YAP1 overexpression counteracted the tumor-suppressive effects of miR-199a-3p in vitro.

Conclusions:

• miR-199a-3p functions as a tumor suppressor in ovarian cancer by inhibiting cell viability.
• The tumor-suppressive mechanism involves the direct inhibition of the oncogene YAP1.
• miR-199a-3p holds promise as a potential biomarker and therapeutic target for ovarian cancer.